The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...

Scientists have been focusing more on nasal vaccines — like the flu vaccine FluMist that was recently approved for at-home use — as a way to overcome these social and practical challenges to ...